| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |